
PDL BioPharma Inc. (NASDAQ: PDLI) dropped 5% on Monday to post a new 52-week low of $6.52 against a 52-week high of $10.26. The stock closed at $6.87 on Friday night. Volume was about equal to the daily average of around 4 million shares. The company had no specific news today, but is scheduled to report first quarter results on Wednesday.
3D Systems Corp. (NYSE: DDD) dropped 1.6% on Monday to add to post a new 52-week low of $24.51 after closing at $24.92 on Friday. The stock’s 52-week high is $69.56. Share volume was about 30% below the daily average of around 2.8 million shares traded. The company announced a distribution deal this morning, but the stock price fades as investors await first quarter results, also due Wednesday from the 3D printer maker.
Zulily Inc. (NASDAQ: ZU) also posted a second consecutive 52-week low on Monday. Shares dropped 2.2% to $11.88 from Friday’s closing price of $12.15. The stock’s 52-week high is $50.39. Volume was about 10% above the daily average of around 2.6 million shares. The company had no news today.
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) dropped about 10% on Monday to post a new 52-week low of $9.80 after closing at $10.90 on Friday. The stock’s 52-week high is $18.48. Share volume was more than double the daily average of around 1.6 million shares traded. The company reported a first quarter loss this morning.
ALSO READ: 15 Companies Losing the Most Money
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.